Dementia Clinical Trial
Official title:
Pharmacogenic Guidance to Optimize Safety and Efficacy of Psychotropic Drug Use in Treatment of Behavioral and Psychiatric Symptoms in Dementia
Investigators propose to determine whether knowing details about how a person's genes affect the way medicines work in the brain and body will help doctors pick more effective or safer medicine for that person. Target symptoms are restlessness, agitation, depression and related problems common in people with memory loss and dementia.
This project offers an innovative approach to improving treatment outcomes for people with
Behavioral and psychiatric symptoms of dementia (BPSD), as well as a novel electronic health
record (EHR) -compatible means of assessing treatment response. To date, there has been
limited investigation of pharmacogenomic testing among people with dementia. Testing has
mostly been focused on testing a single Cytochrome P450 (CYP)polymorphism to guide treatment
decisions for cognitive enhancing cholinesterase inhibitor medications in patients with
Alzheimer disease. Pharmacogenomic guidance of prescribing decisions for psychotropic
medications has not been studied for BPSD but there is growing evidence that such analyses
can assist in effective prescription decisions for treatment of depression. Since affective
symptoms are among the most prominent drivers of BPSD and associated distress, and the
highest level evidence for successful treatment of BPSD is with the antidepressant drug
citalopram, investigators believe that pharmacogenomic guidance for selection of drugs to
treat BPSD is truly innovative, and will provide new insights on implementing safer and more
effective treatment for BPSD.
Additionally, investigators will explore the use of the NIH-sponsored Patient Reported
Outcomes measurement Information System (PROMIS) as an outcome measure for BPSD. PROMIS is a
system of highly reliable, valid, flexible, precise, and responsive assessment tools that
measure patient-reported health status. PROMIS measures are available for typical BPSD like
anger, anxiety, and depression, but their utility has not been studied in a sample of
dementia patients. They offer the potential, through patient-portal EHR interfaces, for
clinicians to track treatment responses in a more timely and efficient manner than
traditional clinic-based instruments, placing less burden on patients and families to present
for in-clinic assessments.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05686486 -
Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes
|
N/A | |
Terminated |
NCT05451693 -
Outreach-ER: A Dementia Care Intervention Program
|
||
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Enrolling by invitation |
NCT06040294 -
Dementia and Disability Simulation for College Nursing Students' Senior Activity Facilitation Skills
|
N/A | |
Completed |
NCT05114187 -
An Internet-Based Education Program for Care Partners of People Living With Dementia
|
N/A | |
Recruiting |
NCT06322121 -
Vascular Aspects in Dementia: Part 2
|
||
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
Recruiting |
NCT03462485 -
Pilot Study of the Effects of Playing Golf on People With Dementia
|
N/A | |
Active, not recruiting |
NCT03677284 -
Managing Time With Dementia: Effects of Time Assistive Products in People With Dementia
|
N/A | |
Completed |
NCT03849937 -
Changing Talk Online (CHATO) Study
|
N/A | |
Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Completed |
NCT04571697 -
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Recruiting |
NCT06033066 -
Financial Incentives and Recruitment to the APT Webstudy
|
N/A | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT05684783 -
Dementia Champions in Homecare
|
||
Completed |
NCT03147222 -
Function Focused Care: Fracture Care at Home
|
N/A |